Lower ventricular and atrial strain in patients who recovered from COVID-19 assessed by cardiovascular magnetic resonance feature tracking

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00159816%3A_____%2F23%3A00079664" target="_blank" >RIV/00159816:_____/23:00079664 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216224:14110/23:00132254 RIV/00216305:26220/23:PU150988

Výsledek na webu

<a href="https://www.frontiersin.org/articles/10.3389/fcvm.2023.1293105/full" target="_blank" >https://www.frontiersin.org/articles/10.3389/fcvm.2023.1293105/full</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.3389/fcvm.2023.1293105" target="_blank" >10.3389/fcvm.2023.1293105</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Lower ventricular and atrial strain in patients who recovered from COVID-19 assessed by cardiovascular magnetic resonance feature tracking

Popis výsledku v původním jazyce

IntroductionOne of the most common complications of coronavirus disease 2019 (COVID-19) is myocardial injury, and although its cause is unclear, it can alter the heart&apos;s contractility. This study aimed to characterize the ventricular and atrial strain in patients who recovered from COVID-19 using cardiovascular magnetic resonance feature-tracking (CMR-FT).MethodsIn this single-center study, we assessed left ventricle (LV) and right ventricular (RV) global circumferential strain (GCS), global longitudinal strain (GLS), global radial strain (GRS), left atrial (LA) and right atrial (RA) longitudinal strain (LS) parameters by CMR-FT. The student&apos;s t-test and Wilcoxon rank-sum test were used to compare the variables.ResultsWe compared seventy-two patients who recovered from COVID-19 (49 +/- 16 years) to fifty-four controls (49 +/- 12 years, p = 0.752). The patients received a CMR examination 48 (34 to 165) days after the COVID-19 diagnosis. 28% had LGE. Both groups had normal LV systolic function. Strain parameters were significantly lower in the COVID-19 survivors than in controls.DiscussionPatients who recovered from COVID-19 exhibited significantly lower strain in the left ventricle (through LVGCS, LVGLS, LVGRS), right ventricle (through RVGLS and RVGRS), left atrium (through LALS), and right atrium (through RALS) than controls.

Název v anglickém jazyce

Lower ventricular and atrial strain in patients who recovered from COVID-19 assessed by cardiovascular magnetic resonance feature tracking

Popis výsledku anglicky

IntroductionOne of the most common complications of coronavirus disease 2019 (COVID-19) is myocardial injury, and although its cause is unclear, it can alter the heart&apos;s contractility. This study aimed to characterize the ventricular and atrial strain in patients who recovered from COVID-19 using cardiovascular magnetic resonance feature-tracking (CMR-FT).MethodsIn this single-center study, we assessed left ventricle (LV) and right ventricular (RV) global circumferential strain (GCS), global longitudinal strain (GLS), global radial strain (GRS), left atrial (LA) and right atrial (RA) longitudinal strain (LS) parameters by CMR-FT. The student&apos;s t-test and Wilcoxon rank-sum test were used to compare the variables.ResultsWe compared seventy-two patients who recovered from COVID-19 (49 +/- 16 years) to fifty-four controls (49 +/- 12 years, p = 0.752). The patients received a CMR examination 48 (34 to 165) days after the COVID-19 diagnosis. 28% had LGE. Both groups had normal LV systolic function. Strain parameters were significantly lower in the COVID-19 survivors than in controls.DiscussionPatients who recovered from COVID-19 exhibited significantly lower strain in the left ventricle (through LVGCS, LVGLS, LVGRS), right ventricle (through RVGLS and RVGRS), left atrium (through LALS), and right atrium (through RALS) than controls.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30201 - Cardiac and Cardiovascular systems

Projekt

<a href="/cs/project/NU22-A-121" target="_blank" >NU22-A-121: Role imunitního systému při vzniku poškození myokardu u pacientů s onemocněním COVID-19.</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2023

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Frontiers in Cardiovascular Medicine

ISSN

2297-055X

e-ISSN

—

Svazek periodika

10

Číslo periodika v rámci svazku

NOV 2023

Stát vydavatele periodika

CH - Švýcarská konfederace

Počet stran výsledku

9

Strana od-do

1293105

Kód UT WoS článku

001106564100001

EID výsledku v databázi Scopus

—